-

CYBE Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of CyberOptics Corporation Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of CyberOptics Corporation (NASDAQ: CYBE) to Nordson Corporation for $54.00 per share is fair to CyberOptics shareholders.

Halper Sadeh encourages CyberOptics shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether CyberOptics and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for CyberOptics shareholders; (2) determine whether Nordson is underpaying for CyberOptics; and (3) disclose all material information necessary for CyberOptics shareholders to adequately assess and value the merger consideration. On behalf of CyberOptics shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages CyberOptics shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLP

NASDAQ:CYBE

Release Versions

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLP

TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Bio-Techne Corporation (NASDAQ: TECH) to Merck KGaA for $73.00 per share in cash. Halper Sadeh encourages Bio-Techne shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Bio-Techne and its board of directors violat...

PPC Stock Alert: Halper Sadeh LLC is Investigating Whether Pilgrim’s Pride Corporation is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the proposed sale of Pilgrim’s Pride Corporation (NASDAQ: PPC) to JBS N.V. for 2.086 JBS Class A common shares for each Pilgrim’s Pride share of common stock. JBS currently owns approximately 82% of Pilgrim’s Pride common stock. The investigation concerns whether this consideration undervalues the company and whether the process leading to it is fair and adequate.Halper Sadeh encourages Pilgrim’s Pride sha...

WEAV Investigation Alert: Halper Sadeh LLC is Investigating Whether Weave Communications, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Weave Communications, Inc. (NYSE: WEAV) to Francisco Partners for $7.40 per share in cash. Halper Sadeh encourages Weave shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Weave and its board of directors violate...
Back to Newsroom